Closed
SectorHealthcare
10.98 2.33
24h
Min
10.75
Max
11.02
Income | 212M 25M |
---|---|
Sales | 4.5M 9M |
EPS | -0.199 |
Profit margin | 280.018 |
Employees | 908 |
EBITDA | -52M -274M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +324.66% upside |
Market Cap | 7.2B |
---|---|
Previous open | 8.65 |
Previous close | 10.98 |
By Trading Central
Confidence
Very Strong Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 44.25 USD 324.66%
High 129 USD
Low 12 USD
Based on 7 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$